This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jim Cramer's Stop Trading: Time to 'Re-Rate' the Insurance Industry

Stocks in this article: PRU MET GNW TRV PL

NEW YORK (TheStreet) -- The whole life insurance industry is due for a "re-rating," TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, reasoned on CNBC's "Cramer's Stop Trading" segment. 

He elaborated, saying that companies like Prudential Financial (PRU) -- which is having a successful investors' day today -- MetLife  (MET) and Genworth Financial (GNW) should trade with higher valuations. 

And while The Travelers Companies (TRV) is simply too big to be taken over and is not a life insurance provider, it runs a "fantastic" business and is a "remarkable insurer," he said.

This "re-rating" follows Japanese insurer Dai-ichi's purchase of Protective Life (PL) for $70 per share, or roughly $5.7 billion. This takeover is making investors reconsider the valuation for life insurance companies, Cramer concluded.

-- Written by Bret Kenwell in Petoskey, Mich.

>>Read More:

Instagram Chases the Art of the Perfect Selfie With Newfangled Tools

Pandora Trash Talks Apple, Is Google Ready to Back It Up?

What Is an Industrial Vending Machine and Why Are Sales on Fire?

Marvel Film Woes Cast Shadow Over Disney's Recent Stock Pop

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs